Protagonist Therapeutics (PTGX) PT Raised to $145 at Truist Securities

July 7, 2026 6:03 AM

Truist Securities analyst Srikripa Devarakonda raised the price target on Protagonist Therapeutics (NASDAQ: PTGX) to $145.00 (from $121.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found